KFSHRC's Dr. Björn Zoéga Honoured With C3 Global Innovative Healthcare Award At NYC Summit

Dr. Björn Zoéga, Deputy CEO of King Faisal Specialist Hospital & Research Centre (KFSHRC), recently received the C3 Global Innovative Healthcare & Impact Transformation Award. This accolade was presented at the NYC C3 Summit Davos of Healthcare, highlighting KFSHRC's leadership in healthcare innovation and transformation.

The summit featured key presentations on biotechnology, artificial intelligence, robotics, and precision medicine. As a C3 Strategic Partner and Scientific Committee Chair, KFSHRC played a crucial role in shaping discussions about the future of healthcare and addressing significant global challenges.

KFSHRC leaders led sessions on advanced medical technologies during the summit. Dr. Edward Cupler, Executive Director of Research and Innovation, discussed Saudi Arabia's emergence as a global biotech leader. Dr. Feras Khaliel explored robotics in surgery, while Dr. Salah Baz highlighted whole genome sequencing's potential for diagnosing rare diseases and advancing personalized care.

The award given to Zoéga recognises KFSHRC's dedication to enhancing healthcare through innovative solutions. The centre aims to expand access to healthcare while reducing costs and promoting sustainability and social responsibility.

KFSHRC is committed to expanding its global partnerships to deliver accessible, patient-centered, technology-driven healthcare solutions worldwide. The hospital ranked first in the Middle East and Africa for the second consecutive year among the world's top 250 Academic Medical Centers.

According to Brand Finance's 2024 rankings, KFSHRC is recognised as the most valuable healthcare brand in Saudi Arabia and the Middle East. Newsweek magazine also listed it among the world's best 250 hospitals this year.

With inputs from SPA